Dr. Karl Linter, CEO at Kal’Idees and "daddy" of Sederma’s award-winning Matrixyl explains how he and his team developed the active ingredient. He talks about the origins: The team found a little peptide in the literature which stimulates collagen synthesis. The development took about two year from the first idea to its launch. He explains the mechanism of the collagen stimulation and talks about what potential he sees for peptides in the future.